-
William Blair Upgrades Medpace, Sees 'Strong Biotechnology Funding Environment'
Tuesday, July 31, 2018 - 2:35pm | 331Read More...Medpace Holdings Inc (NASDAQ: MEDP) reported better-than-expected second-quarter earnings Monday afternoon. The Analyst William Blair's John Kreger upgraded Medpace from Market Perform to Outperform. The Thesis The company reported adjusted EPS of 67 cents on an ASC 605 basis in...
-
The State Of Chinese Company Take-Private Offers: A Look At WuXi PharmaTech
Thursday, November 19, 2015 - 8:24am | 1239Read More...Chinese “Go-Private” deals have littered the PR feeds of investors with increased uncertainty in the global macro environment. Often times, executive management teams of these Chinese companies see value taking the company private and re-listing back in China. While nothing would look...



